Health insurer Cigna will stop covering GLP-1 weight loss drugs in its employee health plan

Summary

CNBC's Becky Quick reports that Cigna will stop covering GLP-1 weight loss drugs for its employees starting July 1. The anchors discuss the financial strain these drugs are placing on employer and government budgets, with examples of school budget cuts and rising healthcare costs.

• Cigna stops covering GLP-1 weight loss drugs in employee health plan effective July 1.
• Current users can pay cash or use discount programs like TrumpRx.
• Becky Quick highlights that insurance companies themselves are rejecting coverage due to high costs.
• Public budgets at schools and local governments are blowing up from unexpected drug costs.
• Medicare and Medicaid costs are reportedly rising 30% year-over-year instead of 5%.
• Joe Kernen notes short-term budget pressures leading to teacher layoffs and property tax increases.
• The long-term potential cost savings from GLP-1 drugs are debated against immediate financial pain.
• No explicit trade recommendations are made in the segment.